Previous 10 | Next 10 |
The retail sector is lower on a combination of Omicron COVID developments and a weaker-than-anticipated retail sales report. Omicron is spreading quickly in the UK to raise concerns outbreaks in the U.S. could lead to lower foot traffic at stores or reduced economic activity. As for the ...
Salesforce (NYSE: CRM) reports better-than-expected profits and promotes Bret Taylor to co-CEO. Square (NYSE: SQ) plans to change its name to Block. Jack Dorsey steps down as CEO of Twitter (NYSE: TWTR) . And Docusign (NASDAQ: DOCU) plummets on weak guidance....
Strong results in the third quarter (Q3) are overshadowed by Salesforce 's (NYSE: CRM) guidance for Q4, but maybe the company's second attempt at a Co-CEO structure will improve the picture for shareholders. Shares of Box (NYSE: BOX) pop 12% as the cloud storage company cont...
Retail stocks such as Nike (NKE) and Allbirds (BIRD) are well poised to derive outsized gains to long-term investors. Nike’s consistent performance and the ongoing increase in digital sales positions the company to beat the broader indexes. Alternatively, Allbirds’ narrowing los...
Robinhood (NASDAQ:HOOD), Oatly (NASDAQ:OTLY), Honest Company (NASDAQ:HNST) and many other of 2021’s seemingly hottest IPOs sank to all-time lows Friday as fears of Omicron and tighter Federal Reserve policies apparently drove investors away from recently public stocks. “With all...
Allbirds co-CEO Joseph Zwillinger blamed an error involving the company's share count for the wider-than-expected loss that sent its shares reeling by nearly 17% in the wake of its first earnings report since going public. Speaking to CNBC on Wednesday, the co-founder and co-CEO of Allbirds (...
Allbirds (NASDAQ: BIRD) , a footwear and apparel company, reported that its revenue had risen 33% to USD62.7 Million, compared to the previous year. However, its losses magnified as the cost of opening stores and listing its stock affected the end result. Shares fell 6% during e...
Gainers: Arbutus Biopharma (NASDAQ:ABUS) +87%. MDJM (NASDAQ:MDJH) +41%. Context Therapeutics (NASDAQ:CNTX) +35%. Build-A-Bear Workshop (NYSE:BBW) +33%. Ardelyx (NASDAQ:ARDX) +28%. Ambarella (NASDAQ:AMBA) +25%. Roivant Sciences (NASDAQ:ROIV) +22%. Stran & Company (NASDAQ:STRN) +20%. Marpai...
Gainers: Build-A-Bear Workshop (NYSE:BBW) +30%. Stran & Company (NASDAQ:STRN) +16%. Chicken Soup for the Soul Entertainment (NASDAQ:CSSE) +12%. Birks Group (NYSE:BGI) +10%. Partner Communications Company (NASDAQ:PTNR) +8%. Losers: NuZee (NASDAQ:NUZE) -16%. Allbirds (NASDAQ:BIRD)...
Shares of footwear maker and retailer Allbirds (NASDAQ: BIRD) fell sharply as soon as trading got underway on Dec. 1, losing as much as 10% of its value at one point in the first half hour of trading. The big news driving the decline was the company's third-quarter 2021 earnings...
News, Short Squeeze, Breakout and More Instantly...
SAN FRANCISCO, July 17, 2024 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make products in a better way, today announced that its second quarter 2024 financial results will be released after market close on Wednesday, Aug...
SAN FRANCISCO, July 16, 2024 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make products in a better way, today announced that Jason Israel has been named VP of Design, effective June 1. Israel reports to Chief Design Offi...
2024-05-24 05:45:28 ET Allbirds (NASDAQ: BIRD) stock price has become toxic and is now hovering near its all-time low. It has moved from a record high of $32.40 into an unwanted penny stock as investors worry about its future. Subsequently, its market cap has plunged to about $96 millio...